Home > Insider Trading > Filing (0001019056-18-000465)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1671584	Aptevo Therapeutics Inc.	APVO	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1493324	L Marvin White	2401 4Th Avenue, Suite 1050 Seattle WA 98121	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-03-19	100,000	$2.93	166,332	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The purchase price of $2.93 is reflective of the weighted average purchase price. The prices for the transactions reported on this line range from $2.865 to $3.020, inclusive. Mr. White undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
This amendment is being filed to reflect the fact that the reported transaction was a purchase and not a sale of shares of the Issuer by Mr. White. Column 3 of Table I and footnote (1) of this Form 4 as originally filed incorrectly indicated that this transaction was a sale. Those references have been corrected on this amendment to the original Form 4 to reflect that the reported transaction was a purchase.